Evidence map›Paper›PMID 37384647›Full record

ArticlePloS one2023

Is chimerism associated with cancer across the tree of life?

Stefania E Kapsetaki, Angelo Fortunato, Zachary Compton, Shawn M Rupp, Zaid Nour, Skyelyn Riggs-Davis, Dylan Stephenson, Elizabeth G Duke, Amy M Boddy, Tara M Harrison and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Making Neurobots and Chimerical Ctenophores.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Stefania E KapsetakiArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.ORCID 0000-0002-9999-8573
Angelo FortunatoArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Zachary ComptonArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Shawn M RuppArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Zaid NourArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Skyelyn Riggs-DavisArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Dylan StephensonDepartment of Psychology, Arizona State University, Tempe, AZ, United States of America.
Elizabeth G DukeArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Amy M BoddyArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Tara M HarrisonArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Carlo C MaleyArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Athena AktipisArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, United States of America.
Biocom · USArizona State University · USNorth Carolina State University · USUniversity of California, Santa Barbara · US

Funding

PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233254 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY · 2018 to 2023
$11.4M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
T32 Cancer Prevention and Control Training Program Addressing Health DisparitiesT32CA272303 · NCI · UNIVERSITY OF ARIZONA · PI Terry A Badger, Gloria D. Coronado · 2023 to 2026
$1.1M
A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineageR21CA257980 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MALEY, CARLO, WEISS, RON · 2022 to 2023
$576k
NCI NIH HHS P01 CA091955NCI NIH HHS R01 CA140657NCI NIH HHS R21 CA257980NCI NIH HHS T32 CA272303NCI NIH HHS U2C CA233254NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

Chimerism is a widespread phenomenon across the tree of life. It is defined as a multicellular organism composed of cells from other genetically distinct entities. This ability to 'tolerate' non-self cells may be linked to susceptibility to diseases like cancer. Here we test whether chimerism is associated with cancers across obligately multicellular organisms in the tree of life. We classified 12 obligately multicellular taxa from lowest to highest chimerism levels based on the existing literature on the presence of chimerism in these species. We then tested for associations of chimerism with tumour invasiveness, neoplasia (benign or malignant) prevalence and malignancy prevalence in 11 terrestrial mammalian species. We found that taxa with higher levels of chimerism have higher tumour invasiveness, though there was no association between malignancy or neoplasia and chimerism among mammals. This suggests that there may be an important biological relationship between chimerism and susceptibility to tissue invasion by cancerous cells. Studying chimerism might help us identify mechanisms underlying invasive cancers and also could provide insights into the detection and management of emerging transmissible cancers.

Indexed as

ChimerismNeoplasmsAnimalsMammals

Identifiers

PMID37384647
PMCPMC10309991
OpenAlexW4382601410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.